Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

ByBrian Drapeau

July 16th 2026

Mid-Year Check-In: Are Henrik Johanning's Pharma Manufacturing Predictions Holding Up?

ByHenrik Johanning

July 15th 2026

Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer

ByBrian Drapeau

June 16th 2026

Concept image of the six most common questions | Image Credit: © RTimages - stock.adobe.com

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

ByChristopher Cole

November 19th 2025

Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two

ByPatrick Lavery

November 7th 2025

Drug Safety Concerns Shape Manufacturing Policy

Articles in this issue

Related Content

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

Mid-Year Check-In: Are Henrik Johanning's Pharma Manufacturing Predictions Holding Up?

Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two

Trending on Pharmaceutical Technology

FDA Activity Round Up – July 2026

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One

Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching